Modified successful desensitization protocol of infliximab in a patient with sarcoidosis unable to tolerate corticosteroids and refractory to alternative therapeutics.

Tepetam, Fatma Merve; Bayraktar, Ravza; Çetinkaya, Erdogan; Tanriverdi, Elif; Demirkol, Baris

Tepetam, Fatma Merve; Bayraktar, Ravza; Çetinkaya, Erdogan; Tanriverdi, Elif; Demirkol, Baris.

Afiliación

Tepetam FM; Clinic of Immunology and Allergy, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.
Bayraktar R; Clinic of Immunology and Allergy, Süreyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.
Çetinkaya E; Clinic of Pulmonology, Yedikule Training and Research Hospital, Istanbul, Türkiye.
Tanriverdi E; Clinic of Pulmonology, Yedikule Training and Research Hospital, Istanbul, Türkiye.
Demirkol B; Clinic of Pulmonology, Yedikule Training and Research Hospital, Istanbul, Türkiye.

Tuberk Toraks ; 70(4): 397-402, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36537098

Asunto(s)

Anticuerpos Monoclonales; Sarcoidosis; Humanos; Infliximab/uso terapéutico; Anticuerpos Monoclonales/efectos adversos; Sarcoidosis/patología; Corticoesteroides/uso terapéutico; Factor de Necrosis Tumoral alfa

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoidosis / Anticuerpos Monoclonales Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Tuberk Toraks Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google